Assuming multiple is required, the following results were found.

  • Coronavirus and MS Reporting Database Announced by Consortium of Multiple Sclerosis Centers & National Multiple Sclerosis Society

    Coronavirus and MS Reporting Database Announced by Consortium of Multiple Sclerosis Centers & National Multiple Sclerosis Society Click HERE to Register for the MS Beacon Newsletter COVID-19 – WHAT HAVE WE LEARNED SO FAR? Authors: Katrina Mountfort,...

    https://mschristian.org/index.php/component/easyblog/coronavirus-and-ms-reporting-database-announced-by-consortium-of-multiple-sclerosis-centers-national-multiple-sclerosis-society?Itemid=341
  • Trials and Tribulations: Neurology Research During COVID-19 - Medscape

    pivotal trials on hold, the COVID-19 pandemic is slowing the pace of research in Alzheimer's disease (AD), stroke, and multiple sclerosis (MS). However, researchers remain determined to forge ahead — with many redesigning their studies, at least in part...

    https://mschristian.org/index.php/articles/2-uncategorised/10686-trials-and-tribulations-neurology-research-during-covid-19-medscape
  • How new gene discoveries could guide precision medicine in multiple sclerosis

    by Arlene Weintraub | Oct 31, 2019 10:20am Variants in three "complement" genes are closely associated with vision loss in multiple sclerosis, Johns Hopkins Medicine researchers discovered. (Pixabay) The most severe form of multiple sclerosis, called...

    https://mschristian.org/index.php/component/easyblog/how-new-gene-discoveries-could-guide-precision-medicine-in-multiple-sclerosis?Itemid=341
  • Multiple sclerosis drug slows brain shrinkage, study finds

    Results from a clinical trial of more than 250 participants with progressive multiple sclerosis (MS) revealed that ibudilast was better than a placebo in slowing down brain shrinkage. The study also showed that the main side effects of ibudilast were...

    https://mschristian.org/index.php/component/easyblog/multiple-sclerosis-drug-slows-brain-shrinkage-study-finds?Itemid=341
  • Boston Children's Hospital researchers seem to have pinpointed the cause of multiple sclerosis

    Targeting a rogue T cell prevents and reverses multiple sclerosis in mice This could be a very significant development in medical research. The press release about it just came out today. I’m sorry I can’t go into as much detail as I’d like because I...

    https://mschristian.org/index.php/component/easyblog/boston-children-s-hospital-researchers-seem-to-have-pinpointed-the-cause-of-multiple-sclerosis?Itemid=341
  • Environmental factors may trigger onset of multiple sclerosis

    that certain environmental conditions may precipitate structural changes that take place in myelin sheaths in the onset of multiple sclerosis (MS). Myelin sheaths are the "insulating tape" surrounding axons; axons carry electrical impulses in neurons....

    https://mschristian.org/index.php/component/easyblog/environmental-factors-may-trigger-onset-of-multiple-sclerosis?Itemid=341
  • Researchers relate neuropsychological tests with real-life activity in multiple sclerosis

    between neuropsychological assessment and predictability of performance of everyday life activities among people with multiple sclerosis (MS). The article, "Beyond cognitive dysfunction: Relevance of ecological validity of neuropsychological tests in...

    https://mschristian.org/index.php/component/easyblog/researchers-relate-neuropsychological-tests-with-real-life-activity-in-multiple-sclerosis?Itemid=341
  • #ECTRIMS2019 - Transplanting MSCs Safe, Helps Stop Progressive MS - Multiple Sclerosis News Today

    Transplanting mesenchymal stem cells (MSCs) is safe and can delay disease progression in people with active, progressive multiple sclerosis (MS), according to results from a single-center clinical trial conducted in Israel. Six months after the...

    https://mschristian.org/index.php/component/easyblog/ectrims2019-transplanting-mscs-safe-helps-stop-progressive-ms-multiple-sclerosis-news-today?Itemid=341
  • Social cognition, mood and fatigue in multiple sclerosis

    A recent study by Kessler Foundation researchers linked the deficits in social cognition in multiple sclerosis with symptoms in other domains. The article, "Relationship between social cognition and fatigue, depressive symptoms, and anxiety in multiple...

    https://mschristian.org/index.php/component/easyblog/social-cognition-mood-and-fatigue-in-multiple-sclerosis?Itemid=341
  • How metabolites target brain-homing immune cells to treat multiple sclerosis

    Advanced Science Research Center, GC/CUNY. "How metabolites target brain-homing immune cells to treat multiple sclerosis: The discovery could lead to novel, more specific, and more effective MS therapies and a better understanding of how the disease...

    https://mschristian.org/index.php/component/easyblog/how-metabolites-target-brain-homing-immune-cells-to-treat-multiple-sclerosis?Itemid=341
  • Targeting Bruton Tyrosine Kinase for Multiple Sclerosis Treatment

    An in-depth look into the expanding landscape of multiple sclerosis treatments that target bruton tyrosine kinase. By: Jennifer S. Sun, PhD - June 30, 2020 Bruton Tyrosine Kinase (BTK), a Tec family nonreceptor tyrosine kinase1 critical for the...

    https://mschristian.org/index.php/component/easyblog/targeting-bruton-tyrosine-kinase-for-multiple-sclerosis-treatment?Itemid=101
  • Robotic exoskeleton helps woman with multiple sclerosis walk - WJXT News4JAX

    Sign up for our Newsletters Latest News Health Despite having multiple sclerosis, Kathy Miska can walk with the assistance of a robotic exoskeleton that is programmed to meet her needs. (Cleveland Clinic News Service) Kathy Miska, 56, of Strongsville,...

    https://mschristian.org/index.php/component/easyblog/robotic-exoskeleton-helps-woman-with-multiple-sclerosis-walk-wjxt-news4jax?Itemid=341
  • Compound in fruit peels can reduce and reverse neuronal damage in multiple sclerosis

    Reviewed by Emily Henderson, B.Sc.Apr 6 2020 Multiple sclerosis (MS), characterized by increasing muscle weakness and paralysis, has a number of treatments that help stall progression of the disease when used early on in the disease. But the current...

    https://mschristian.org/index.php/articles/2-uncategorised/10499-compound-in-fruit-peels-can-reduce-and-reverse-neuronal-damage-in-multiple-sclerosis
  • Our vulnerable nervous system: What affects its protective sheaths?

    According to the Deutsche Multiple Sklerose Gesellschaft (German Multiple Sclerosis Society), around 200,000 people in Germany suffer from multiple sclerosis (MS) -- a serious neurological condition that has no known cure. Although the causes are far...

    https://mschristian.org/index.php/articles/2-uncategorised/9140-our-vulnerable-nervous-system-what-affects-its-protective-sheaths
  • New 6-Year Data for Genentech’s Ocrevus (ocrelizumab) Show Earlier Treatment Initiation Nearly Halves Risk of Needing Walking Aid in Relapsing Multiple Sclerosis

    extension studies showed Ocrevus treatment reduced the risk of needing a walking aid (EDSS≥6) by 49% in relapsing multiple sclerosis (RMS) patients compared with patients who switched from interferon beta-1a two years later – – Separate analysis showed...

    https://mschristian.org/index.php/articles/2-uncategorised/10699-new-6-year-data-for-genentech-s-ocrevus-ocrelizumab-show-earlier-treatment-initiation-nearly-halves-risk-of-needing-walking-aid-in-relapsing-multiple-sclerosis
  • Bristol Myers Squibb Announces Commercial Launch and Availability of ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

    that ZEPOSIA® (ozanimod) 0.92 mg, a new once-daily oral medication for adults for the treatment of relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive...

    https://mschristian.org/index.php/articles/2-uncategorised/10832-bristol-myers-squibb-announces-commercial-launch-and-availability-of-zeposia-ozanimod-a-new-oral-treatment-for-relapsing-forms-of-multiple-sclerosis
  • Benefits of Tai Chi for Multiple Sclerosis

    Tai Chi, also called Tai Chi Chuan, is an ancient Chinese martial art that has evolved into a multiple-element form of exercise, featuring slow, gentle, dance-like movements that encourage deep breathing and relaxation, improve balance, and strengthen...

    https://mschristian.org/index.php/articles/2-uncategorised/10894-benefits-of-tai-chi-for-multiple-sclerosis
  • Multiple Sclerosis Medications: How The Drugs Work, in Under 5 minutes! [2020]

    Information Shared by: MSViewsandNews, to and for those affected by Multiple Sclerosis ::::::::::::::::::::::::::::::::::::::;;;;;;;;;;;;;;;;;;;;;::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: Visit our MS Learning Channel on YouTube:...

    https://mschristian.org/index.php/articles/2-uncategorised/10892-multiple-sclerosis-medications-how-the-drugs-work-in-under-5-minutes-2020
  • Severe COVID-19 in Multiple Sclerosis Linked to Disability Status, Age, Obesity

    July 01, 2020 Céline Louapre, MD, PhD In a recent attempt to understand the risk factors involved for patients with multiple sclerosis (MS) to possibly develop a severe form of the novel COVID-19 infection, results suggest that neurological disability,...

    https://mschristian.org/index.php/articles/2-uncategorised/10917-severe-covid-19-in-multiple-sclerosis-linked-to-disability-status-age-obesity
  • Global Autoimmune Drugs Market 2020 COVID-19 Updated Analysis By Product (Rheumatoid Arthritis (RA), Multiple Sclerosis (MS), Psoriasis, Inflammatory Bowel Disease (IBD), Ankylosing Spondylitis (AS), Systemic Lupus Erythematosus (SLE)); By Application (Ho

    the market with more clarity. The market segments of the Autoimmune Drugs market includes {Rheumatoid Arthritis (RA), Multiple Sclerosis (MS), Psoriasis, Inflammatory Bowel Disease (IBD), Ankylosing Spondylitis (AS), Systemic Lupus Erythematosus (SLE)};...

    https://mschristian.org/index.php/articles/2-uncategorised/10951-global-autoimmune-drugs-market-2020-covid-19-updated-analysis-by-product-rheumatoid-arthritis-ra-multiple-sclerosis-ms-psoriasis-inflammatory-bowel-disease-ibd-ankylosing-spondylitis-as-systemic-lupus-erythematosus-sle-by-application-hospital-clinic-red-black-student-newspaper

Results 181 - 200 of 874